Loading data for CDT — first visit, this takes a few seconds.
CDT Equity Inc. (CDT)
NasdaqCM: CDT
· Real-Time Price · USD
2.86
-0.04 (-1.38%)
At close: Aug 21, 2026, 10:11 AM
The price, the headline numbers and the latest news, in one place.
CDT Equity Inc. (CDT) Stock Price, Analysis & Data
-1.38% (1D)
| Bid | 2.39 |
| Market Cap | 2.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -37.15M |
| 1.49 | |
| -2978.78 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.02 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 12, 2025 |
| Ask | 3.71 |
| Volume | 78,216 |
| Avg. Volume (20D) | 729,439 |
| Open | 2.99 |
| Previous Close | 2.90 |
| Day's Range | 2.85 - 3.40 |
| 52-Week Range | 2.53 - 3460.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CDT
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, wh...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2022
Employees 4
Stock Exchange NasdaqCM
Ticker Symbol CDT
Website https://www.cdtequity.com
Financial Performance
In 2025, CDT Equity's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -39.22M, an increase of 120.33%.
Financial StatementsCDT Equity Inc. is scheduled to release its earnings on Nov 12, 2025, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
